Skip to main content
. Author manuscript; available in PMC: 2014 Nov 25.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Nov;2(11):931–941. doi: 10.1158/1940-6207.CAPR-09-0121

Table 3.

Efficacy outcomes (n=39)

GTE
Efficacy Parameter Placebo
(n=11)
500 mg/m2
(n=11)
750 mg/m2
(n=8)
1000 mg/m2
(n=9)
All GTE doses
(n=28)
P-value
Clinical Response 18.2% 50% 0.09

CR 0 1 0 0 1
PR 2 3 5 5 13
SD 4 4 1 1 6
PD 5 3 2 3 8

Histologic Response 9.1% 21.4% 0.65

PR 1 3 0 3 6
SD 7 5 5 3 13
PD 3 3 3 3 9